Lonitoclax is an investigational new drug that is being evaluated by Lomond Therapeutics for the treatment of acute myeloid leukemia (AML) and chronic lymphocytic leukaemia (CML).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.